De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry
暂无分享,去创建一个
André M Deelder | Bernhard Kuster | Albert Heck | Benjamin Balluff | Manfred Schmitt | Liam A McDonnell | Michaela Aubele | Heinz Höfler | Axel Walch | Stefan K. Maier | B. Kuster | H. Höfler | A. Walch | L. McDonnell | B. Balluff | A. Heck | M. Schmitt | M. Aubele | P. Hogendoorn | A. Deelder | C. Frese | Cédrik Schöne | Christian K Frese | Pancras C W Hogendoorn | Cédrik Schöne | Stefan K Maier | Johannes Morreau | A F Maarten Altelaar | J. Morreau | A. M. Maarten Altelaar | M. Schmitt | AF Maarten Altelaar
[1] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[2] J. Salk. Clonal evolution in cancer , 2010 .
[3] Jorge S Reis-Filho,et al. Genetic heterogeneity and cancer drug resistance. , 2012, The Lancet. Oncology.
[4] W. N.,et al. THE PATHOLOGICAL SOCIETY OF GREAT BRITAIN AND IRELAND , 1906 .
[5] Michael Becker,et al. Analysis and interpretation of imaging mass spectrometry data by clustering mass-to-charge images according to their spatial similarity. , 2013, Analytical chemistry.
[6] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[7] Sören-Oliver Deininger,et al. MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. , 2008, Journal of proteome research.
[8] P. Delvenne,et al. Organized proteomic heterogeneity in colorectal cancer liver metastases and implications for therapies , 2014, Hepatology.
[9] L. McDonnell,et al. Peptide and protein imaging mass spectrometry in cancer research. , 2010, Journal of proteomics.
[10] L. Nadauld,et al. Molecular profiling of gastric cancer: toward personalized cancer medicine. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Carissa A. Sanchez,et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.
[12] R. Caprioli,et al. Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation , 2010, Clinical Cancer Research.
[13] Bernhard Kuster,et al. Comprehensive Identification of Proteins from MALDI Imaging* , 2013, Molecular & Cellular Proteomics.
[14] Emrys A. Jones,et al. Imaging mass spectrometry-based molecular histology differentiates microscopically identical and heterogeneous tumors. , 2013, Journal of proteome research.
[15] Liam A. McDonnell,et al. Imaging mass spectrometry data reduction: Automated feature identification and extraction , 2010, Journal of the American Society for Mass Spectrometry.
[16] Garry L Corthals,et al. MSiMass list: a public database of identifications for protein MALDI MS imaging. , 2014, Journal of proteome research.
[17] S. Rauser,et al. MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. , 2011, The American journal of pathology.
[18] D. Ward,et al. Identification of macrophage migration inhibitory factor and human neutrophil peptides 1–3 as potential biomarkers for gastric cancer , 2009, British Journal of Cancer.
[19] Carlos Caldas,et al. The implications of clonal genome evolution for cancer medicine. , 2013, The New England journal of medicine.
[20] Richard M Caprioli,et al. Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. , 2010, Journal of proteome research.
[21] C. Swanton. Intratumor heterogeneity: evolution through space and time. , 2012, Cancer research.
[22] S. Rauser,et al. Direct molecular tissue analysis by MALDI imaging mass spectrometry in the field of gastrointestinal disease. , 2012, Gastroenterology.
[23] Richard M Caprioli,et al. Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. , 2013, Chemical reviews.
[24] E. Solary,et al. Human defensins as cancer biomarkers and antitumour molecules. , 2009, Journal of proteomics.
[25] Sandra Rauser,et al. MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology , 2008, Histochemistry and Cell Biology.
[26] Liam A. McDonnell,et al. Multiple Statistical Analysis Techniques Corroborate Intratumor Heterogeneity in Imaging Mass Spectrometry Datasets of Myxofibrosarcoma , 2011, PloS one.
[27] A. Walch,et al. MALDI imaging mass spectrometry for direct tissue analysis. , 2013, Methods in molecular biology.
[28] Charles Swanton,et al. Intratumor Heterogeneity: Seeing the Wood for the Trees , 2012, Science Translational Medicine.
[29] Richard M Caprioli,et al. Protein signatures for survival and recurrence in metastatic melanoma. , 2011, Journal of proteomics.
[30] Darryl Shibata,et al. Clonal diversity in tumor progression , 2006, Nature Genetics.
[31] Marc K Halushka,et al. Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer. , 2010, Human pathology.
[32] M. J. van de Vijver,et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study , 2008, Histopathology.
[33] K. Polyak,et al. Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.
[34] L. F. Waanders,et al. Quantitative proteomic analysis of single pancreatic islets , 2009, Proceedings of the National Academy of Sciences.
[35] André M Deelder,et al. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity , 2010, The Journal of pathology.
[36] Manfred Schmitt,et al. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma. , 2014, Journal of proteome research.
[37] Marius Ueffing,et al. MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma. , 2012, Journal of proteomics.
[38] Graham A. Colditz,et al. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study , 2011, Breast Cancer Research and Treatment.
[39] Pradeep S Rajendran,et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.
[40] P. Chaurand,et al. Processing MALDI Mass Spectra to Improve Mass Spectral Direct Tissue Analysis. , 2007, International journal of mass spectrometry.
[41] Kristina Schwamborn,et al. Molecular imaging by mass spectrometry — looking beyond classical histology , 2010, Nature Reviews Cancer.
[42] Stefan K. Maier,et al. Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria , 2013, The Journal of pathology.
[43] Michelle L. Reyzer,et al. Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. , 2010, Journal of proteome research.